Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria

International Journal of Hematology

Volumn 75, Issue 4, 2002, Pages 434-439

  Gao, Weiqiang ^a   Wang, Zhaoyue ^a   Bai, Xia ^a   Li, Yuyun ^a   Ruan, Changgeng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Diagnosis; Granulocyte; Paroxysmal nocturnal hemoglobinuria; Plasma; Urokinase type plasminogen activator receptor

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; UROKINASE; UROKINASE RECEPTOR; CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ANEMIA; ANTIGEN DETECTION; APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENZYME BLOOD LEVEL; FLOW CYTOMETRY; FLUORESCENCE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; ADOLESCENT; ADULT; AGED; BLOOD; CASE CONTROL STUDY; FEMALE; IMMUNOASSAY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SOLUBILITY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD55; ANTIGENS, CD59; CASE-CONTROL STUDIES; FEMALE; GRANULOCYTES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SOLUBILITY;

EID: 0041658372     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982138     Document Type: Article

References (25)

1. Yeh ETH, Rosse WF. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidyl-inositol anchor. J Clin Invest. 1994;93:2305-2310.
2. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
3. Miyata T, Takeda J, Iida Y, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993;259:1318-1320.
4. Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal hemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994;13:110-117.
5. Armstrong C, Schubert J, Ueda E, et al. Affected paroxysmal nocturnal T lymphocytes harbour a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1-murine lymphoma mutants. J Biol Chem. 1992;267:25347-25351.
6. Hillmen P, Bessler M, Mason PJ, et al. Specific defect in N-acetylglucosamine incorporation in the GPI anchor synthetic pathway in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1993;90:5272-5276.
7. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood. 1995;86:4650-4655.
8. Rosti V. The molecular basis of paroxysmal nocturnal hemoglobinuria. Haematologica. 2000;85:82-87.
9. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal hemoglobinuria by phenotypic analysis of erythrocytes using two-color flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol. 1993;85:378-385.
10. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-5340.
11. Plesner T, Ralfkiær E, Wittrup M, et al. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol. 1994;102:835-841.
12. Ploug M, Eriksen J, Plesner T, Hansen NE, Danø K. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur J Biochem. 1992;208:397-404.
13. Ploug M, Plesner T, Rønne E, et al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1992;79:1447-1455.
14. Rønne E, Pappot H, Grøndahl-Hansen J, et al. The receptor for urokinase-type plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal hemoglobinuria. Br J Haematol. 1995;89:576-581.
15. Bai X, Xi X, Xu J, Ruan C. Preparation and identification of monoclonal antibodies against human urokinase receptor. Acta Acad Med Suzhou. 1999;19:1268-1270.
16. Hsi ED. Paroxysmal nocturnal hemoglobinuria testing by flow cytometry: evaluation of the REDQUANT and CELLQUANT kits. Am J Clin Pathol. 2000;114:798-806.
17. Gao W, Wang Z, Bai X, Xi X, Ruan C. Detection of soluble urokinase receptor by immunoradiometric assay and its application in tumor patients. Thromb Res. 2001;102:25-31.
18. Zhang ZN, Guo WH, Liu EK. Clinical experience in the diagnosis for paroxysmal nocturnal hemoglobinuria. Chin J Intern Med. 1995;34:540-542.
19. Rosse WF. Paroxysmal nocturnal hemoglobinuria. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. New York: Churchill Livingstone; 2001:331-342.
20. Pakdeesuwan K, Wanachiwanawin W, Siripanyaphinyo U, Pattanapanyasat K, Wilairat P, Issaragrisil S. Immunophenotypic discrepancies between granulocytic and erythroid lineages in peripheral blood of patients with paroxysmal nocturnal haemoglobinuria. Eur J Haematol. 2000;65:8-16.
21. Piedras J, Lopez-Karpovitch X. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size. Cytometry. 2000;42:234-238.
22. Schrezenmeier H, Hildebrand A, Rojewski M, Hacker H, Heimpel H, Raghavachar A. Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue? Acta Haematol. 2000;103:41-48.
23. Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the uPA-uPAR-PAI-1 system. Thromb Haemost. 1999;82:298-304.
24. Pedersen TL, Yong K, Pedersen JO, Hansen NE, Danø K, Plesner T. Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal hemoglobinuria. Br J Haematol. 1996;95:45-51.
25. Ninomiya H, Hasegawa Y, Nagasawa T, Abe T. Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity. Int J Hematol. 1997;65:285-291.